Northwestern University Translational Research in Hematology-Oncology T32 Training Program
The Northwestern University Translational Research in Hematology-Oncology (NU-TRIHO) Training Program seeks to develop the next generation of physician scientists in hematology/oncology. It provides educational and research experiences that integrate and bridge basic and clinical sciences, thereby establishing a solid foundation for translational research. Open to existing Northwestern University adult and pediatric hematology-oncology fellows, each trainee receives two years of support to conduct laboratory or clinical research under the mentorship of established, well-funded investigators. Supplementing the research training, the educational component of the program includes:
- Grant Writing
- Biostatistics
- Clinical Trial Design
- Responsible Conduct of Research
- Scientific Rigor and Reproducibility
- Translational Research Journal Club
The NU-TRIHO Training Program is funded by the National Cancer Institute as an institutional National Research Search Award (T32CA268935). In addition to salary support, trainees receive an allocation for supplies, travel, and tuition. For more information, contact Hidayatullah Munshi, MD.
Program Leadership
Hidayatullah Munshi, MD
Program Director
Robert and Lora Lurie Professor of Medicine
Professor of Medicine (Hematology and Oncology)
Maha Hussain, MBChB
Program Director
Genevieve E. Teuton Professor of Medicine
Professor of Medicine (Hematology and Oncology)
Benette Phillips, PhD
Program Administrative Director
Scientific Program Director, Lurie Cancer Center
Laboratory Research Preceptors
Mohamed Abazeed, MDDepartment of Radiation Oncology
Radiation oncologySarki Abdulkadir, MD, PhDDepartment of Urology
Mechanisms of prostate cancer initiation, progression, and recurrenceJaehyuk Choi, MD, PhDDepartment of Dermatology
Genomics-based approaches to identify the genetic basis of inherited and acquired immunological disorders and skin cancerLillian Eichner, PhDDepartments of Biochemistry and Molecular Genetics
Transcriptional dependencies in cancer development, progression, and resistance mechanismsElizabeth Eklund, MDDepartment of Medicine (Hematology/Oncology)
Molecular biology of late myeloid differentiationAmy Heimberger, MDDepartment of Neurological Surgery
Mechanisms of tumor-mediated immune suppression and identifying actionable targets for immune therapeuticsDai Horiuchi, PhDDepartment of Pharmacology
Cellular events that influence the aggressiveness of breast tumorsMaria Luisa Iruela-Arispe, PhDDepartment of Cell and Developmental Biology
Morphogenesis and homeostasis of vasculature, role of VEGF and Notch signaling in blood vessels and cancer Shannon Lauberth, PhDDepartment of Biochemistry and Molecular Genetics
High-throughput NGS technologies, state of the art microscopy techniques, quantitative proteomics, biochemistry, and cell-based/genetic assaysXiaonan Li, MD, PhDDepartment of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation)
Development of novel patient-derived orthotopic xenograft mouse models
Huiping Liu, MD, PhDDepartments of Pharmacology and Medecine (Hematology and Oncology)
Molecular mechanisms underlying cancer stem cells and metastasisDaniela Matei, MDDepartments of Obstetrics and Gynecology (Gynecologic Oncology) and Medicine (Hematology and Oncology)
Finding new treatments to eradicate ovarian cancer stem cells and improve outcomes for womenHidayatullah Munshi, MDDepartment of Medicine (Hematology and Oncology)
Biology of pancreatic cancer and pre-clinical studies in pancreatic cancer Leonidas Platanias, MD, PhDDepartment of Medicine (Hematology and Oncology)
Cytokine-signaling in malignant cells and mechanisms of signal transduction and arsenic trioxideBin Zhang, MD, PhDDepartments of Medicine (Hematology and Oncology) and Microbiology-Immunology
Immunotherapy Clinical Research Preceptors
Jessica Altman, MDDepartment of Medicine (Hematology and Oncology)
Leukemia clinical trials, phase I cancer clinical trials and cancer guideline developmentAl B. Benson III, MDDepartment of Medicine (Hematology and Oncology)
Gastrointestinal cancer clinical trials, cancer clinical trials, biologic therapies, phase I cancer clinical trials and cancer guideline developmentYoung Kwang Chae, MDDepartment of Medicine (Hematology and Oncology)
Personalized cancer therapySunandana Chandra, MDDepartment of Medicine (Hematology and Oncology)
Novel biomarkers as prognostic and predictive tools in the management of melanoma andother advanced skin cancersWilliam Gradishar, MDDeaprtment of Medicine (Hematology and Oncology)
Breast cancer clinical/translational trials investigating novel chemotherapeutic agents, endocrine therapy and targeted therapyMaha Hussain, MBChBDepartment of Medicine (Hematology and Oncology)
Development of novel therapeutics integrating scientific advances into clinical trials in prostate and bladder cancer Devalingam Mahalingam, MBBChBAODepartment of Medicine (Hematology and Oncology)
Developmental therapeuticsJonathan Moreira, MDDepartment of Medicine (Hematology and Oncology)
Hematopoietic stem cell transplantation for hematologic and solid malignanciesJyoti Patel, MDDepartment of Medicine (Hematology and Oncology)
Development and evaluation of novel molecular markers and therapeutics in patients battling non-small cell lung cancerSeth Pollack, MDDepartment of Medicine (Hematology and Oncology)
Sarcoma and immune-based therapiesNiraj Shenoy, MD, PhDDepartments of Medicine (Hematology and Oncology) and Pathology
Understanding and targeting the interactions between aberrant metabolism, epigenetic dysregulation, immune evasion, and hypoxia signaling in cancerJeffrey Sosman, MDDepartment of Medicine (Hematology and Oncology)
Immune-based therapy of melanomaAngela Waanders, MD, MPHDepartment of Pediatrics (Hematology and Oncology)
Developing novel therapeutic strategies for children with brain and spinal cord tumorsDavid Walterhouse, MDDepartment of Pediatrics (Hematology and Oncology)
Function and regulation of the oncogene GLIJane Winter, MDDepartment of Medicine (Hematology and Oncology)
Hematologic malignancies and hematopoietic stem cell transplantation 